Wockhardt wins “BIRAC Innovator Award 2024”
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Subscribe To Our Newsletter & Stay Updated